Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$522K Sell
1,479
-54
-4% -$19.3K 0.34% 53
2025
Q4
$502K Buy
1,533
+91
+6% +$28.9K 0.3% 58
2025
Q3
$407K Buy
1,442
+48
+3% +$13.9K 0.26% 69
2025
Q2
$389K Sell
1,394
-9
-0.6% -$2.55K 0.28% 66
2025
Q1
$437K Sell
1,403
-18
-1% -$5.32K 0.45% 53
2024
Q4
$370K Buy
1,421
+11
+0.8% +$3.26K 0.36% 68
2024
Q3
$454K Buy
1,410
+13
+0.9% +$4.25K 0.46% 54
2024
Q2
$436K Buy
1,397
+20
+1% +$5.88K 0.48% 49
2024
Q1
$390K Sell
1,377
-37
-3% -$10.8K 0.47% 56
2023
Q4
$407K Buy
+1,414
New +$385K 0.53% 48

Other funds holding AMGN

OneFund LLC's AMGN Position: Q1 2026 in Review

OneFund LLC reduced its Amgen (AMGN) stake by 3.5% in Q1 2026, selling an estimated $19.3K and leaving 1,479 shares worth $522K. The position accounts for 0.34% of the portfolio, ranked #53.

OneFund LLC first reported a position in AMGN in Q4 2023 and has held it in 10 quarters since. 3,131 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.

  • OneFund LLC held 1,479 shares of Amgen worth $522K as of Q1 2026.
  • OneFund LLC sold 54 Amgen shares in Q1 2026, an estimated $19.3K.
  • Amgen made up 0.34% of OneFund LLC's portfolio in Q1 2026, its #53 holding.
  • OneFund LLC first reported a position in Amgen in Q4 2023 and has held it in 10 quarters since.
  • 3,131 funds tracked by Wall St. Rank held Amgen as of Q1 2026.

Based on OneFund LLC's 13F filing for Q1 2026, filed 8 May 2026.